INTERNATIONAL PATENT: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE DE MONTPELLIER (UM) FILES APPLICATION FOR "NK CELL-DERIVED EXTRACELLULAR VESICLES ARMED WITH RECOMBINANT POLYPEPTIDE TO TARGET CANCER CELLS AND USE THEREOF"

GENEVA, April 28 -- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3 Rue Michel-Ange75016 Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (101 rue de Tolbiac75013 Paris), UNIVERSITE DE MONTPELLIER (UM) (163 Rue Auguste Broussonnet34090 Montpellier) filed a patent application (PCT/EP2025/080031) for "NK CELL-DERIVED EXTRACELLULAR VESICLES ARMED WITH RECOMBINANT POLYPEPTIDE TO TARGET CANCER CELLS, AND USE THEREOF" on Oct 17, 2025. With publication no. WO/2026/082936, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO...